NIH supports exploratory and developmental research addressing critical needs in Down syndrome to improve health and quality of life; clinical trials are not allowed.
NIH supports transformative research on Down syndrome and co-occurring conditions by individual scientists or teams, with no preliminary data required and no clinical trials allowed.
NIH supports milestone-driven Down syndrome clinical trial development with up to two years of planning and a possible three-year clinical trial phase, for a maximum of five years.
This grant invites researchers to submit biospecimens for omics analysis to study Down syndrome, generating shared data to advance understanding of related health conditions; no direct funding is provided.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
INCLUDE Voices: Research in Action Challenge supports community members and researchers creating videos that explain Down syndrome research’s value and encourage informed participation.